C-K Lee

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. ncbi Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantation
    C K Lee
    The Myeloma Institute for Research and Therapy, The University of Arkansas for Medical Sciences, Little Rock, AR, USA
    Bone Marrow Transplant 37:511-5. 2006
  2. ncbi Transplantation as salvage therapy for high-risk patients with myeloma in relapse
    C-K Lee
    The Myeloma Institute for Research and Therapy, The University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    Bone Marrow Transplant 30:873-8. 2002
  3. ncbi Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant
    C K Lee
    The Myeloma Institute for Research and Therapy, The University of Arkansas for Medical Sciences, Little Rock, 72205, USA
    Bone Marrow Transplant 33:823-8. 2004
  4. ncbi Prophylactic T cell infusion after T cell-depleted bone marrow transplantation in patients with refractory lymphoma
    C-K Lee
    Department of Internal Medicine, Division of Hematology, Oncology, Blood and Marrow Transplantation, University of Iowa, College of Medicine, Iowa City, IA, USA
    Bone Marrow Transplant 29:615-20. 2002
  5. ncbi Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft
    C-K Lee
    Department of Internal Medicine, College of Medicine, The University of Iowa, IA, USA
    Bone Marrow Transplant 31:121-8. 2003
  6. ncbi Acute abdominal pain in systemic lupus erythematosus: factors contributing to recurrence of lupus enteritis
    Y G Kim
    Ann Rheum Dis 65:1537-8. 2006

Detail Information

Publications6

  1. ncbi Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantation
    C K Lee
    The Myeloma Institute for Research and Therapy, The University of Arkansas for Medical Sciences, Little Rock, AR, USA
    Bone Marrow Transplant 37:511-5. 2006
    ....
  2. ncbi Transplantation as salvage therapy for high-risk patients with myeloma in relapse
    C-K Lee
    The Myeloma Institute for Research and Therapy, The University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    Bone Marrow Transplant 30:873-8. 2002
    ..001). Their survival at 2 years post-ST was 43%, 17% and 11%, respectively. Our study suggests further transplantation should only be considered in the setting of a clinical trial in patients with favorable prognostic factors...
  3. ncbi Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant
    C K Lee
    The Myeloma Institute for Research and Therapy, The University of Arkansas for Medical Sciences, Little Rock, 72205, USA
    Bone Marrow Transplant 33:823-8. 2004
    ..05). Our data suggest that significant renal failure can be reversible and AT should be considered early in the disease course...
  4. ncbi Prophylactic T cell infusion after T cell-depleted bone marrow transplantation in patients with refractory lymphoma
    C-K Lee
    Department of Internal Medicine, Division of Hematology, Oncology, Blood and Marrow Transplantation, University of Iowa, College of Medicine, Iowa City, IA, USA
    Bone Marrow Transplant 29:615-20. 2002
    ..001. The study shows that patients with chronic GVHD have superior survivals, most probably related to a graft-versus-lymphoma effect, which could be modulated by prophylactic T cell infusion...
  5. ncbi Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft
    C-K Lee
    Department of Internal Medicine, College of Medicine, The University of Iowa, IA, USA
    Bone Marrow Transplant 31:121-8. 2003
    ..Although the incidence of relapse was low, the study suggests that the current scheme of DLI in unrelated TCD-BMT would not improve survival unless TRM decreases significantly...
  6. ncbi Acute abdominal pain in systemic lupus erythematosus: factors contributing to recurrence of lupus enteritis
    Y G Kim
    Ann Rheum Dis 65:1537-8. 2006